You are here: Industry Insights > PharmaSources.com

News List

Becoming Contracted Authors of PharmaSources PharmaSources.com
February 26, 2024
Join PharmaSources.com to share your insights into the pharmaceutical industry with hundreds of industrial KOLs in a league!
Pharma Sources Insight April 2022: An Overview on BIopharma and API in China and the World Pharma Sources Insight
March 29, 2022
Pharma Sources Insight APRIL 2022 focuses on the universal COVID-19 vaccine, Chinese API, pharma packaging, global biopharma trends and more.
Weekly Pharma News Review | PharmaSources.com (March 28 to April 1) PharmaSources.com
April 07, 2022
The failure of Phase III clinical trials targeting the popular target TIGIT monoclonal antibody has once again put tumor immunotherapy on the radar this week. The pharma news review of this week from March 28 to April 1 covers a total of 25 pieces of news
Weekly Pharma News Review | PharmaSources.com (March 21 to 25) PharmaSources/Caicai
March 30, 2022
Henlius PD-1 was launched this week, becoming the 7th China-made PD-1 monoclonal antibody and the 13th PD-1/PD-L1 monoclonal antibody that was marketed in China.
Weekly Pharma News Review | PharmaSources.com (March 14 to 18) PharmaSources/Caicai
March 25, 2022
One of the most exciting news of this week was the marketing approval of duvelisib capsules, a dual PI3K inhibitor introduced by CSPC Pharmaceutical Group Co., Ltd.
Weekly Pharma News Review | PharmaSources.com (March 7 to 12) PharmaSources.com
March 16, 2022
The news review of this week is from March 7 to 12, covering a total of 20 pieces of information in 4 sections, i.e. review, R&D, business, and listing.
Weekly Pharmaceutical News Review | PharmaSources.com (Feb. 28th to March.4th) PharmaSources.com
March 16, 2022
The most talked-about news of this week is the successful overseas marketing of Nanjing LEGN.US's CAR-T, which not only demonstrates the strength of China's innovative biologics but also eases the anxiety of Chinese innovative drug companies.
Weekly Pharmaceutical News Review of PharmaSources.com (February 21st -25th) PharmaSources/Caicai
February 28, 2022
21st -25th Feb. is the statistical time for the weekly review that covers four sections, Review, R&D, Trading, Investment & Financing, and IPO, and contains 18 pieces of information.
Weekly Pharmaceutical News Review of PharmaSources.com (January 17th to 21st) PharmaSources/Caicai
January 25, 2022
The news review in this week is from January 17 to 21, covering a total of 19 pieces of information in 4 sections, i.e. review, transaction, R&D, and listing.
Weekly Pharma News Review of PharmaSources.com (January 10th to 14th) PharmaSources/Caicai
January 21, 2022
This week in review is the news from January 10-14, covering a total of 15 pieces of information in 3 sections, i.e. review, transaction, and R&D.